Gary K. Lee
LYELGary K. Lee serves as officer: Chief Scientific Officer at Lyell Immunopharma, Inc. (LYEL). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.
Gary K. Lee's Insider Trading at Lyell Immunopharma, Inc. (LYEL)
Buys
0 · $0.00
Sells
6 · $105.3K
Total Shares Bought
0
Total Shares Sold
5,494
Related Insiders
Venture Fund XIII, L.P. ARCH
10 percent owner
LYELBuy · Mar 6, 2026
Venture Partners IX, LLC ARCH
10 percent owner
LYELBuy · Mar 6, 2026
Lynn Seely
President and CEO
LYELSell · Feb 11, 2026
Stephen J. Hill
Chief Operating Officer
LYELSell · Feb 11, 2026
Stephen J. Hill
officer: Chief Operating Officer
LYELSell · Feb 11, 2026
Lynn Seely
director, officer: President and CEO
LYELSell · Feb 11, 2026
Veronica Sanchez Bulis
officer: VP, Corporate Controller
LYELSell · Feb 10, 2026
Veronica Sanchez Bulis
VP, Corporate Controller
LYELSell · Feb 10, 2026